Search Results for 'min egfr'

min egfr published presentations and documents on DocSlides.

Prise en charge des patients
Prise en charge des patients
by ethlyn
insuffisants cardiaques ET insuffisants rénaux :....
BackgroundAcutekidneyinjuryAKIischaracterizedbyelevatedserumcreatini
BackgroundAcutekidneyinjuryAKIischaracterizedbyelevatedserumcreatini
by udeline
invasiveandnon-invasivemeasurementofintraoperative...
Glomerular Filtration Rate, Chronic Kidney Disease, and Transplant Eligibility
Glomerular Filtration Rate, Chronic Kidney Disease, and Transplant Eligibility
by kaiden438
Assumed background knowledge: basic nephron physio...
A brief overview of CKD
A brief overview of CKD
by sadie
Harshani D. Perera . Senior Registrar – Nephrolo...
The Kidney Failure Risk Equation (KFRE)
The Kidney Failure Risk Equation (KFRE)
by victoria
1. KFRE Description. KFRE is a well validated risk...
Diabetic nephropathy s.Jafary
Diabetic nephropathy s.Jafary
by singh
. nodushan. Fellow of endocrinology. R...
Chronic Kidney Disease The Basics
Chronic Kidney Disease The Basics
by stefany-barnette
Kevin Harley, M.D.. Assistant Clinical Professor....
Serum
Serum
by conchita-marotz
Creatinine. . and . eGFR. . Where . A. re . W. ...
Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi
Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi
by conchita-marotz
A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borka...
 Drug  a nd  Herbal  Induced
Drug a nd Herbal Induced
by celsa-spraggs
N. ephrotoxicity. Sayamon. . S. ukkha. . P. har...
Clinical Controversies:  Recent Updates for Medication Use in Chronic Kidney Disease
Clinical Controversies: Recent Updates for Medication Use in Chronic Kidney Disease
by amey
Tracy Anderson-Haag, . PharmD. , BCPS. Clinical Ph...
Safety   of  Tenofovir
Safety of Tenofovir
by deandre922
Alafenamide. in Renal Impairment. A Pozniak. 1. ,...
UK Renal Registry   18th Annual Report
UK Renal Registry 18th Annual Report
by joyce
Figure 3.1. .. Transplant prevalence rate per mil...
x0000x0000Tel 613 8603111   Fax 613 860377 Dalhousie Street
x0000x0000Tel 613 8603111 Fax 613 860377 Dalhousie Street
by harmony
The standards of the Canadian Associat ion of Radi...
Chronic Kidney Disease and Cardiovascular Risk
Chronic Kidney Disease and Cardiovascular Risk
by Younggunner
Heather Mascio, DO. Introduction. Chronic Kidney D...
CKD    Nilang Patel Epidemiology of CKD
CKD Nilang Patel Epidemiology of CKD
by pamela
Definition of CKD. Staging of CKD. Etiology of CKD...
Serum  Creatinine   and
Serum Creatinine and
by valerie
eGFR. . Where . A. re . W. e Now?. Dr Mike Bosomw...
A PCP’s Guide to CKD Screening and Delaying Progression
A PCP’s Guide to CKD Screening and Delaying Progression
by luanne-stotts
Learning Objectives. Utilize appropriate screenin...
High Impact Publication
High Impact Publication
by yoshiko-marsland
. Steven B. Maron. , Lindsay Alpert, . Heewon. ...
Clinical  Management Module
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
Renal Replacement Therapy: What the PCP Needs to Know
Renal Replacement Therapy: What the PCP Needs to Know
by tatiana-dople
Learning Objectives. Describe treatment options f...